HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

RIPL peptide

IPLVVPLRRRRRRRRC

Networked: 5 relevant articles (1 outcomes, 0 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Amino Acids, Peptides, and Proteins: 1
- Peptides: 82426
  - Cell-Penetrating Peptides: 734
    - RIPL peptide: 5

Experts

1.	Choi, Young Wook: 5 articles (06/2020 - 08/2014)
2.	Kang, Myung Joo: 4 articles (06/2020 - 08/2014)
3.	Kim, Chang Hyun: 4 articles (06/2020 - 05/2017)
4.	Yoon, Ho Yub: 4 articles (06/2020 - 05/2017)
5.	Kang, Tae Hoon: 2 articles (06/2020 - 01/2018)
6.	Goh, Min Su: 2 articles (01/2018 - 01/2018)
7.	Lee, Eun Seok: 2 articles (01/2018 - 01/2018)
8.	Lee, Sang Gon: 2 articles (01/2018 - 08/2014)
9.	Sung, Si Woo: 2 articles (01/2018 - 05/2017)
10.	Kang, Min Hyung: 2 articles (05/2017 - 08/2014)

Related Diseases

1.	Ovarian Neoplasms (Ovarian Cancer) 06/15/2020 - "Enhanced docetaxel delivery using sterically stabilized RIPL peptide-conjugated nanostructured lipid carriers: In vitro and in vivo antitumor efficacy against SKOV3 ovarian cancer cells." 06/15/2020 - "For efficient targeting of DTX to hepsin-overexpressing SKOV3 ovarian cancer cells, PEGylated and RIPL peptide (IPLVVPLRRRRRRRRC)-conjugated nanostructured lipid carriers (PEG-RIPL-NLCs) were examined for in vitro and in vivo antitumor efficacy. "
2.	Neoplasms (Cancer) 01/01/2018 - "RIPL peptide (IPLVVPLRRRRRRRRC)-conjugated nanostructured lipid carriers (RIPL-NLCs) can facilitate selective drug delivery to hepsin (Hpn)-expressing cancer cells, but they exhibit low stability in the blood. " 01/01/2018 - "To facilitate selective and enhanced drug delivery to hepsin (Hpn)-expressing cancer cells, RIPL peptide (IPLVVPLRRRRRRRRC, 16-mer)-conjugated nanostructured lipid carriers (RIPL-NLCs) were developed. " 01/01/2018 - "RIPL peptide-conjugated nanostructured lipid carriers for enhanced intracellular drug delivery to hepsin-expressing cancer cells." 08/01/2014 - "To facilitate selective drug delivery to hepsin (Hpn)-expressing cancer cells, the RIPL peptide (IPLVVPLRRRRRRRRC; 16mer; 2.1 kDa) was synthesized as a novel cell penetrating/homing peptide (CPHP) and conjugated to a liposomal carrier. " 08/01/2014 - "RIPL peptide (IPLVVPLRRRRRRRRC)-conjugated liposomes for enhanced intracellular drug delivery to hepsin-expressing cancer cells."

Related Drugs and Biologics

1.	Lipids
2.	Docetaxel (Taxotere)
3.	hepsin
4.	Liposomes (Liposome)
5.	Peptides (Polypeptides)
6.	Fluorescent Dyes (Fluorescent Probes)